Submitted by Anonymous (not verified) on 24 April 2026 - 11:00
Human medicines European public assessment report (EPAR): Itvisma, onasemnogene abeparvovec, Status: Opinion
Source:
Human medicines European public assessment report (EPAR): Itvisma, onasemnogene abeparvovec, Status: Opinion